focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 560.00
Bid: 562.00
Ask: 574.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.135%)
Open: 560.00
High: 0.00
Low: 0.00
Prev. Close: 560.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

14 Feb 2024 07:00

RNS Number : 0365D
Bloomsbury Publishing PLC
14 February 2024
 

TRADING UPDATE - 14 February 2024

Revenue and profit significantly ahead of upgraded expectations. New Bloomsbury US President appointed.

Bloomsbury Publishing Plc (LSE: BMY), the leading independent publisher, is pleased to announce the following update on trading.

Full year outlook

Ø Revenue and profit before taxation and highlighted items are now expected to be significantly ahead of upgraded market expectations for the year ending 29 February 2024.

Ø The Board considers that the consensus market expectation for the year ending 29 February 2024 is currently revenue of £291.4 million and profit before taxation and highlighted items of £37.2 million.

Highlights

Ø The Consumer division has delivered exceptional growth driven in part by the publication on 30th January of Sarah J. Maas novel House of Flame and Shadow which reached Number 1 in the US, UK, Australia and many markets around the world.

Ø The publication of her latest novel has also driven demand for her previous 15 books which Bloomsbury has published throughout the world in the English language. Bloomsbury has a further 6 titles under contract with Sarah J. Maas.

Ø Fantasy has become extremely popular around the world. According to Nielsen Bookscan, in the UK the Fantasy and Sci-Fi genre has grown by 54% in the last five years. Bloomsbury publishes Sarah J. Maas and also fantasy bestselling author Samantha Shannon, Women's Prize winner Susanna Clarke, the iconic Alan Moore, and Cixin Liu, whose Three Body Problem trilogy film adaptation is being released with huge fanfare by Netflix on March 21st, produced by Game of Thrones' David Benioff and D.B. Weiss.

Ø Bloomsbury is investing further in fantasy writing on the newly launched Bloomsbury General list.

Ø Other important recent bestsellers are:

· Ghosts, the bestselling companion book to the BBC smash hit television series,

· Poppy Cooks: The Actually Delicious Air Fryer Cookbook by Poppy O'Toole, 

· Pub Kitchen by Tom Kerridge, 

· The House of Doors by Tan Twan Eng in the US,

· The Harry Potter Wizarding Almanacthe official companion to J.K. Rowling's books, 

· We're Going on a Sleigh Ride by Martha Mumford and Cherie Zamazing and

· Impossible Creatures by Katherine Rundell; a Number 1 bestseller in the UK market and chosen as The Waterstones Book of the Year 2023.

Ø Bloomsbury has appointed Sabrina McCarthy President of Bloomsbury US, starting at the beginning of April. She will also serve on Bloomsbury's global Executive Committee. McCarthy brings experience of general and academic publishing, joining from Ingram Publisher Services where she is Vice President and General Manager. Over the last eight years, she has overseen six distribution brands as well as the domestic, international print and digital sales teams, and the business operations team.

Nigel Newton, Chief Executive, commented: "I am overjoyed to report an exceptionally strong period of trading, principally driven by the increasing demand for fantasy fiction. Sarah J. Maas is a publishing phenomenon and we are very fortunate to have signed her up with her first book 13 years ago. Her books have a huge audience which continues to grow backed by major Bloomsbury promotional campaigns, driving strong word of mouth recommendation, particularly through TikTok and Instagram channels."

The Company will provide further details for the year ended 29 February 2024 with its preliminary results announcement on 23 May 2024.

For further information, please contact:

Bloomsbury Publishing Plc

Nigel Newton, Chief Executive

nigel.newton@bloomsbury.com

Penny Scott-Bayfield, Group Finance Director

penny.scott-bayfield@bloomsbury.com

Tamsin Garrity, Head of Investor Relations

tamsin.garrity@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Hattie Dreyfus

bloomsbury@hudsonsandler.com

 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

The information in this announcement has not been audited or otherwise independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. None of the Company or any of its affiliates, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss whatsoever arising from any use of this announcement, or its contents, or otherwise arising in connection with this announcement.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares of the Company.

Certain statements, statistics and projections in this announcement are or may be forward looking. By their nature, forward?looking statements involve a number of risks, uncertainties or assumptions that may or may not occur and actual results or events may differ materially from those expressed or implied by the forward-looking statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Accordingly, forward-looking statements contained in this announcement regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. You should not place undue reliance on forward-looking statements, which are based on the knowledge and information available only at the date of this announcement's preparation.

The Company does not undertake any obligation to update or keep current the information contained in this announcement, including any forward?looking statements, or to correct any inaccuracies which may become apparent and any opinions expressed in it are subject to change without notice.

References in this announcement to other reports or materials, such as a website address, have been provided to direct the reader to other sources of information on Bloomsbury Publishing Plc which may be of interest. Neither the content of Bloomsbury's website nor any website accessible by hyperlinks from Bloomsbury's website nor any additional materials contained or accessible thereon, are incorporated in, or form part of, this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFTFFIVLIS
Date   Source Headline
29th Jul 201512:53 pmRNSDirector/PDMR Shareholding
29th Jul 201512:49 pmRNSDirector/PDMR Shareholding
29th Jul 201512:49 pmRNSDirector/PDMR Shareholding
23rd Jul 20154:42 pmRNSAGM Statement
23rd Jul 201512:00 pmRNSDirectorate Change
23rd Jul 20157:00 amRNSTrading Statement
6th Jul 20155:36 pmRNSDirector/PDMR Shareholding
6th Jul 20155:34 pmRNSDirector/PDMR Shareholding
25th Jun 20154:54 pmRNSAnnual Financial Report
18th Jun 201511:27 amRNSHolding(s) in Company
5th Jun 20154:07 pmRNSDirector/PDMR Shareholding
4th Jun 20151:15 pmRNSHolding(s) in Company
4th Jun 20151:13 pmRNSHolding(s) in Company
28th May 20158:28 amRNSHolding(s) in Company
21st May 201510:23 amRNSDirector/PDMR Shareholding
19th May 20155:00 pmRNSBlock Listing Six Monthly Return
19th May 20157:00 amRNSPreliminary Results
18th Mar 20157:00 amRNSTrading Statement
3rd Mar 20153:30 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSTotal Voting Rights
29th Jan 20155:51 pmRNSHolding(s) in Company
9th Jan 20158:37 amRNSDirector/PDMR Shareholding
9th Jan 20158:35 amRNSDirector/PDMR Shareholding
9th Jan 20158:34 amRNSDirector/PDMR Shareholding
24th Dec 201412:23 pmRNSDirector/PDMR Shareholding
24th Dec 201412:20 pmRNSDirector/PDMR Shareholding
24th Dec 201412:19 pmRNSDirector/PDMR Shareholding
23rd Dec 20147:00 amRNSAdditional Listing & Total Voting Rights
22nd Dec 20144:56 pmRNSAcquisition of Osprey Publishing Limited
17th Nov 201410:59 amRNSHolding(s) in Company
17th Nov 201410:57 amRNSBlocklisting Interim Review
13th Nov 20144:01 pmRNSHolding(s) in Company
12th Nov 20144:07 pmRNSHolding(s) in Company
12th Nov 201411:36 amRNSHolding(s) in Company
11th Nov 20143:31 pmRNSHolding(s) in Company
5th Nov 20144:34 pmRNSHolding(s) in Company
30th Oct 20143:29 pmRNSHolding(s) in Company
23rd Oct 20147:00 amRNSInterim Results for six months ended 31 August 14
22nd Oct 20144:51 pmRNSHolding(s) in Company
13th Oct 20149:00 amRNSNotice of Results
8th Oct 201410:42 amRNSTotal Voting Rights
6th Oct 20145:57 pmRNSDirector/PDMR Shareholding
6th Oct 20145:55 pmRNSDirector/PDMR Shareholding
9th Sep 201411:47 amRNSHolding(s) in Company
9th Sep 201411:45 amRNSHolding(s) in Company
2nd Sep 20145:05 pmRNSHolding(s) in Company
6th Aug 20143:05 pmRNSHolding(s) in Company
28th Jul 20141:51 pmRNSBlocklisting Application
22nd Jul 20144:08 pmRNSResult of AGM
10th Jul 20147:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.